GDF15 and metabolic dysfunction-associated steatotic liver disease: A study in a biopsy-proven MASLD cohort of adult subjects revealed that the circulating levels of GDF15 positively correlated with the severity of lobular inflammation, ballooning, and fibrosis, suggesting the potential of GDF15 as a biomarker of advanced fibrosis in MASLD [10].